Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series

As a continuing demand for booster shots against SARS-CoV-2, ocular adverse events following the coronavirus disease-2019 (COVID-19) vaccines can cause significant visual impairment, and they warrant a high awareness and detailed documentation of possible ocular inflammatory manifestations. We prese...

Full description

Bibliographic Details
Main Authors: Ling-Uei Wang, Fang-Ting Chen, Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang, Yun-Ju Chen, Yung-Ray Hsu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Taiwan Journal of Ophthalmology
Subjects:
Online Access:http://www.e-tjo.org/article.asp?issn=2211-5056;year=2022;volume=12;issue=4;spage=465;epage=471;aulast=Wang
_version_ 1811200245845983232
author Ling-Uei Wang
Fang-Ting Chen
Jia-Kang Wang
Tzu-Lun Huang
Pei-Yao Chang
Yun-Ju Chen
Yung-Ray Hsu
author_facet Ling-Uei Wang
Fang-Ting Chen
Jia-Kang Wang
Tzu-Lun Huang
Pei-Yao Chang
Yun-Ju Chen
Yung-Ray Hsu
author_sort Ling-Uei Wang
collection DOAJ
description As a continuing demand for booster shots against SARS-CoV-2, ocular adverse events following the coronavirus disease-2019 (COVID-19) vaccines can cause significant visual impairment, and they warrant a high awareness and detailed documentation of possible ocular inflammatory manifestations. We present a case series of 11 patients presenting with ocular manifestations relevant to vaccine-associated autoimmune response within 6 weeks after the vaccination of the Oxford–AstraZeneca, the Moderna, and Pfizer-BioNTech vaccines at the main tertiary referral center in the most populated and most vaccinated city in Taiwan. Their diagnosis included five acute anterior uveitis, two multiple evanescent white dot syndrome, one probable Vogt–Koyanagi–Harada disease, one anterior scleritis, one relapsed idiopathic panuveitis, and one autoantibody-related central retinal artery occlusion. This report presented a broad spectrum of the ocular inflammatory events following the vaccination of COVID-19. Early recognition of the clinical manifestations mentioned herein with prompt management is crucial in recovering the patients' vision.
first_indexed 2024-04-12T02:01:24Z
format Article
id doaj.art-831e66127d6a4baa80289d13d230e94e
institution Directory Open Access Journal
issn 2211-5056
2211-5072
language English
last_indexed 2024-04-12T02:01:24Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Taiwan Journal of Ophthalmology
spelling doaj.art-831e66127d6a4baa80289d13d230e94e2022-12-22T03:52:40ZengWolters Kluwer Medknow PublicationsTaiwan Journal of Ophthalmology2211-50562211-50722022-01-0112446547110.4103/2211-5056.353129Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case seriesLing-Uei WangFang-Ting ChenJia-Kang WangTzu-Lun HuangPei-Yao ChangYun-Ju ChenYung-Ray HsuAs a continuing demand for booster shots against SARS-CoV-2, ocular adverse events following the coronavirus disease-2019 (COVID-19) vaccines can cause significant visual impairment, and they warrant a high awareness and detailed documentation of possible ocular inflammatory manifestations. We present a case series of 11 patients presenting with ocular manifestations relevant to vaccine-associated autoimmune response within 6 weeks after the vaccination of the Oxford–AstraZeneca, the Moderna, and Pfizer-BioNTech vaccines at the main tertiary referral center in the most populated and most vaccinated city in Taiwan. Their diagnosis included five acute anterior uveitis, two multiple evanescent white dot syndrome, one probable Vogt–Koyanagi–Harada disease, one anterior scleritis, one relapsed idiopathic panuveitis, and one autoantibody-related central retinal artery occlusion. This report presented a broad spectrum of the ocular inflammatory events following the vaccination of COVID-19. Early recognition of the clinical manifestations mentioned herein with prompt management is crucial in recovering the patients' vision.http://www.e-tjo.org/article.asp?issn=2211-5056;year=2022;volume=12;issue=4;spage=465;epage=471;aulast=Wangchoroidintraocular inflammationretinauveitisvascular occlusion
spellingShingle Ling-Uei Wang
Fang-Ting Chen
Jia-Kang Wang
Tzu-Lun Huang
Pei-Yao Chang
Yun-Ju Chen
Yung-Ray Hsu
Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series
Taiwan Journal of Ophthalmology
choroid
intraocular inflammation
retina
uveitis
vascular occlusion
title Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series
title_full Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series
title_fullStr Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series
title_full_unstemmed Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series
title_short Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series
title_sort ocular inflammatory manifestations following covid 19 vaccinations in taiwan a case series
topic choroid
intraocular inflammation
retina
uveitis
vascular occlusion
url http://www.e-tjo.org/article.asp?issn=2211-5056;year=2022;volume=12;issue=4;spage=465;epage=471;aulast=Wang
work_keys_str_mv AT lingueiwang ocularinflammatorymanifestationsfollowingcovid19vaccinationsintaiwanacaseseries
AT fangtingchen ocularinflammatorymanifestationsfollowingcovid19vaccinationsintaiwanacaseseries
AT jiakangwang ocularinflammatorymanifestationsfollowingcovid19vaccinationsintaiwanacaseseries
AT tzulunhuang ocularinflammatorymanifestationsfollowingcovid19vaccinationsintaiwanacaseseries
AT peiyaochang ocularinflammatorymanifestationsfollowingcovid19vaccinationsintaiwanacaseseries
AT yunjuchen ocularinflammatorymanifestationsfollowingcovid19vaccinationsintaiwanacaseseries
AT yungrayhsu ocularinflammatorymanifestationsfollowingcovid19vaccinationsintaiwanacaseseries